Federal contract award
15B20525P00000007
NATIONAL DRUG CODE: 66215-0602-06 GENERIC NAME: SELEXIPAG 200MCG TAB TRADE NAME: UPTRAVI 200MCG TAB VA CLASS: CARDIOVASCULAR AGENTS,OTHER 2X 60-TABLET BOTTLES. 120 TABLETS TOTAL.
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Justice |
| Office | FMC DEVENS |
| NAICS | 325412 — Pharmaceutical Preparation Manufacturing |
| PSC | 6505 — Drugs and Biologicals |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $29.2K |
| Current contract value | $29.2K |
| Potential contract value / ceiling | $29.2K |
| Start date | Oct 29, 2024 |
| Current end date | Nov 1, 2024 |
| Potential end date | Nov 1, 2024 |
| Latest award activity | Oct 29, 2024 |
| Source loaded | Aug 15, 2026 |
Funding and modification history
Showing the latest 1 of 1 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Oct 29, 2024 | 0 | $29.2K | NATIONAL DRUG CODE: 66215-0602-06 GENERIC NAME: SELEXIPAG 200MCG TAB TRADE NAME: UPTRAVI 200MCG TAB VA CLASS: CARDIOVASCULAR AGENTS,OTHER 2X 60-TABLET BOTTLES. 120 TABLETS TOTAL. |
Buyer contacts from matching notices
Matched on exact award/solicitation identifier and awarding agency. Source dates describe the notice, not current contact verification.
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.